Roche Holding AG
RHO5
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2026
Employees
112,774
Roche Holding AG News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,924.20 | 8.30 | -0.09% |
| CAC 40 | 8,089.09 | 173.73 | 2.19% |
| DAX 40 | 24,031.42 | 622.05 | 2.66% |
| Dow JONES (US) | 47,713.14 | 27.66 | -0.06% |
| FTSE 100 | 10,433.40 | 183.88 | 1.79% |
| HKSE | 25,959.90 | 551.44 | 2.17% |
| NASDAQ | 22,674.58 | 21.36 | -0.09% |
| Nikkei 225 | 54,248.39 | 1,519.67 | 2.88% |
| NZX 50 Index | 13,094.37 | 4.46 | -0.03% |
| S&P 500 | 6,780.19 | 15.80 | -0.23% |
| S&P/ASX 200 | 8,692.60 | 11.80 | -0.14% |
| SSE Composite Index | 4,123.14 | 26.54 | 0.65% |